DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
NCRI.
UK clinical guidelines for the use of adjuvant trastuzumab (Herceptin®) with or
following chemotherapy in HER2-positive early breast cancer.
London (UK): NCRI; 2005
Access:
We do not assume any responsibility for the contents of the web pages of other providers.